Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor

Author:  ["Ronald S Veazey","Martin S Springer","Preston A Marx","Jason Dufour","Per Johan Klasse","John P Moore"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Pre-exposure oral prophylaxis with antiviral drugs is a potential method for preventing transmission of human immunodeficiency virus type 1 (HIV-1). We show that oral delivery of CMPD167, a small molecule that binds to the CCR5 coreceptor, for 10–14 d can protect a substantial proportion of macaques from vaginal infection with a CCR5-using virus (SHIV-162P3). The macaques that became infected despite receiving CMPD167 had reduced plasma viremia levels during the earliest stages of infection.

Cite this article

Veazey, R., Springer, M., Marx, P. et al. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor. Nat Med 11, 1293–1294 (2005). https://doi.org/10.1038/nm1321

View full text

>> Full Text:   Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor

The antioxidant function of the p53 tumor suppressor

Platelets mediate cytotoxic T lymphocyte–induced liver damage